Loveland, Ohio – CancerFree KIDS has appointed three new members to its Board of Trustees in a move to “grow more relationships with Greater Cincinnati’s business community and expand its impact in pediatric cancer research”.
“We are strategically putting the pieces together to help take CancerFree KIDS to the next level,” says Al Early, vice president and principal of consulting services, CBTS, and incoming board chair for CancerFree KIDS. “With Javier, Rob, and Tom, we can stay closely aligned with emerging research opportunities while reaching more of Cincinnati’s business leaders and growing the support for vital pediatric cancer initiatives.”
Diaz, Reifsnyder, and Simpson join a board that has also recently seen a change in leadership.
Al Early replaces CancerFree KIDS Founder Ellen Flannery as the new board chair.
In addition to Early’s new role, Kelly Holden, partner, DBL Law has been named vice-chair and Greg Carroll, director, technical support center office of ground water, U.S. Environmental Protection Agency has been named treasurer.
“CancerFree KIDS is a tremendous partner to Ohio cancer researchers,” says Diaz. “I’m excited to join a team that is so clear in its mission to apply revolutionary research to cure high-risk and relapsed cancer in children. Thanks to CancerFree KIDS and the research it has funded, there are kids who are right now enjoying longer, happy lives. I am grateful for this opportunity to help CancerFree KIDS grow these important efforts.”
Founded in 2002, CancerFree KIDS has invested more than $7 million since its inception to fund high-risk, high- reward research initiatives at Cincinnati Children’s Hospital Medical Center in Avondale and Nationwide Children’s Hospital in Columbus. The studies intend to find cures and gentler treatments to help children better cope with the pains and challenges of fighting cancer. In most cases, this research would go unfunded without the support of CancerFree KIDS.
Visit www.cancerfreekids.org to learn more about the organization’s mission and work to fight childhood cancer.